We think EssilorLuxottica will benefit from intangible assets (strong brands, distribution channel access, and research and development platforms) and cost advantage, enabling it to generate economic profits well into the future.
EssilorLuxottica is the leader in the fragmented eyewear industry, more than twice the size of the next-biggest player, which allows manufacturing at scale.
As a serial acquirer, EssilorLuxottica faces operational risk when integrating targets. Further acquisitions could face antitrust hurdles.
|
Metric
|
EL
|
COO
|
|---|---|---|
Price/Earnings (Normalized) | 23.06 | 12.46 |
Price/Book Value | 1.69 | 1.31 |
Price/Sales | 2.30 | 2.66 |
Price/Cash Flow | 11.21 | 11.87 |
|
Metric
|
EL
|
COO
|
|---|---|---|
Quick Ratio | 0.50 | 0.51 |
Current Ratio | 0.89 | 1.22 |
Interest Coverage | 10.54 | 6.18 |
|
Metric
|
EL
|
COO
|
|---|---|---|
Return on Assets (Normalized) | 5.15% | 7.25% |
Return on Equity (Normalized) | 8.49% | 10.89% |
Return on Invested Capital (Normalized) | 6.46% | 9.02% |
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| LOCK|?J^BfJV | LOCK|#Qz | $142B | |||
| Becton Dickinson & Co
BDX
| LOCK|&! | LOCK|%gCDz | $49B | |||
| ResMed Inc
RMD
| LOCK|YYJv&Hs | LOCK|z@ycD | $31B | |||
| Medline Inc Ordinary Shares - Class A
MDLN
| LOCK|#glt#G$ | LOCK|&$>? | $31B | |||
| Alcon Inc
ALC
| LOCK|SJ!STmY | LOCK|lb%%n | $31B | |||
| West Pharmaceutical Services Inc
WST
| LOCK|V<PMXZ&# | LOCK|w!< | $26B | |||
| Solventum Corp
SOLV
| LOCK|P^nh%%C | LOCK|#kC | $15B | |||
| Baxter International Inc
BAX
| LOCK|cgz | LOCK|NRfyH | $12B | |||
| The Cooper Companies Inc
COO
| LOCK|>C^##XF | LOCK|M$#tY | $11B | |||
| Align Technology Inc
ALGN
| LOCK|>?^V^v | LOCK|%?>Y^ | $10B |
United States